Cargando…
Salinomycin inhibits cholangiocarcinoma growth by inhibition of autophagic flux
INTRODUCTION: Cholangiocarcinoma is characterized by aggressive tumor growth, high recurrence rates, and resistance against common chemotherapeutical regimes. The polyether-antibiotic Salinomycin is a promising drug in cancer therapy because of its ability to overcome apoptosis resistance of cancer...
Autores principales: | Klose, Johannes, Guerlevik, Engin, Trostel, Tina, Kühnel, Florian, Schmidt, Thomas, Schneider, Martin, Ulrich, Alexis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790487/ https://www.ncbi.nlm.nih.gov/pubmed/29423070 http://dx.doi.org/10.18632/oncotarget.23339 |
Ejemplares similares
-
Inhibition of Autophagic Flux by Salinomycin Results in Anti-Cancer Effect in Hepatocellular Carcinoma Cells
por: Klose, Johannes, et al.
Publicado: (2014) -
Salinomycin induces autophagic cell death in salinomycin-sensitive melanoma cells through inhibition of autophagic flux
por: Liu, Yajing, et al.
Publicado: (2020) -
Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133(+) human colorectal cancer cells
por: Klose, Johannes, et al.
Publicado: (2016) -
Diosmin Inhibits Glioblastoma Growth through Inhibition of Autophagic Flux
por: Chang, Yung-Lung, et al.
Publicado: (2021) -
Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitro
por: Lieke, Thorsten, et al.
Publicado: (2012)